Amalgamated Bank Buys 4,513 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Amalgamated Bank boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 5.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 91,688 shares of the company's stock after purchasing an additional 4,513 shares during the period. Amalgamated Bank's holdings in GE HealthCare Technologies were worth $7,168,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in GEHC. Allspring Global Investments Holdings LLC boosted its holdings in shares of GE HealthCare Technologies by 2.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company's stock worth $2,317,000 after buying an additional 562 shares during the last quarter. Assenagon Asset Management S.A. raised its position in GE HealthCare Technologies by 10.1% in the third quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company's stock worth $1,289,000 after acquiring an additional 1,256 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of GE HealthCare Technologies by 14.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 53,033 shares of the company's stock worth $4,977,000 after acquiring an additional 6,870 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in shares of GE HealthCare Technologies by 2.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company's stock worth $7,165,000 after purchasing an additional 1,920 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its holdings in GE HealthCare Technologies by 111.1% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 5,792 shares of the company's stock worth $544,000 after purchasing an additional 3,048 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Remove Ads

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded down $2.05 during midday trading on Friday, reaching $87.35. 4,214,406 shares of the company were exchanged, compared to its average volume of 2,887,457. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a market cap of $39.94 billion, a PE ratio of 20.17, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The business's fifty day moving average is $86.17 and its two-hundred day moving average is $86.12. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analyst Upgrades and Downgrades

GEHC has been the subject of several recent research reports. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.